Advocacy intelligence hub — real-time data for patient organizations
M.D. Anderson Cancer Center — PHASE1, PHASE2
Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
FINANCIAL LANDSCAPE SUMMARY
Total programs
Bexxar
(Tositumomab and iodine I 131 tositumomab)Orphan drugstandardGlaxoSmithKline LLC